Abcam, ab266394, Human ATP5G2 knockout HEK-293T cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
ATP5MC2 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-ATP5MC2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Zygosity-Homozygous, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
ATP5G2 also known as ATP synthase subunit c mitochondrial 2 plays a mechanical role in the production of ATP. This protein functions as a component of the Fo subunit of ATP synthase which operates in the mitochondrial membrane. ATP5G2 has a mass of approximately 8.2 kDa and appears in tissues with high energy demand like muscle and nerve cells. The protein's primary role is to facilitate proton translocation across the mitochondrial membrane important for ATP synthesis.
Biological function summary
ATP5G2 contributes to the generation of cellular energy by being part of the ATP synthase complex also called Complex V of the mitochondrial electron transport chain. This complex performs oxidative phosphorylation converting ADP and inorganic phosphate into ATP which fuels various cellular processes. The subunit's function within the complex directly impacts cellular energy yields and efficiency. Its interaction with other ATP synthase subunits is vital for maintaining the function of the entire complex.
Pathways
ATP5G2 integrates into the oxidative phosphorylation pathway which is central to energy metabolism. This pathway is important for the conversion of nutrients into usable energy. ATP5G2 works closely with the NADH dehydrogenase complex (Complex I) to enable effective electron transport and subsequent ATP generation. The intricate coordination between these complexes is necessary for the maintenance of the mitochondrial membrane potential and overall cellular energetics.
Mutations or dysfunction in ATP5G2 can link to mitochondrial disorders such as Leigh syndrome which involves neurodegeneration and energy deficits. The protein's malfunction can disrupt ATP synthesis affecting the energy balance in cells particularly those requiring high ATP levels. Additionally ATP5G2 might contribute to metabolic disorders like diabetes where insulin secretion and action depend on proper energy metabolism. The role of ATP5G2 alongside other ATP synthase subunits highlights its importance in maintaining mitochondrial and cellular function.